1. Home
  2. ADAP vs AUBN Comparison

ADAP vs AUBN Comparison

Compare ADAP & AUBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • AUBN
  • Stock Information
  • Founded
  • ADAP 2008
  • AUBN 1907
  • Country
  • ADAP United Kingdom
  • AUBN United States
  • Employees
  • ADAP N/A
  • AUBN N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • AUBN Major Banks
  • Sector
  • ADAP Health Care
  • AUBN Finance
  • Exchange
  • ADAP Nasdaq
  • AUBN Nasdaq
  • Market Cap
  • ADAP 75.5M
  • AUBN 75.8M
  • IPO Year
  • ADAP 2015
  • AUBN 1995
  • Fundamental
  • Price
  • ADAP $0.27
  • AUBN $24.82
  • Analyst Decision
  • ADAP Buy
  • AUBN
  • Analyst Count
  • ADAP 6
  • AUBN 0
  • Target Price
  • ADAP $1.35
  • AUBN N/A
  • AVG Volume (30 Days)
  • ADAP 644.7K
  • AUBN 1.8K
  • Earning Date
  • ADAP 08-11-2025
  • AUBN 07-22-2025
  • Dividend Yield
  • ADAP N/A
  • AUBN 4.48%
  • EPS Growth
  • ADAP N/A
  • AUBN 717.98
  • EPS
  • ADAP N/A
  • AUBN 1.88
  • Revenue
  • ADAP $179,639,000.00
  • AUBN $31,155,000.00
  • Revenue This Year
  • ADAP N/A
  • AUBN N/A
  • Revenue Next Year
  • ADAP $35.48
  • AUBN N/A
  • P/E Ratio
  • ADAP N/A
  • AUBN $13.24
  • Revenue Growth
  • ADAP 878.53
  • AUBN 38.25
  • 52 Week Low
  • ADAP $0.20
  • AUBN $16.75
  • 52 Week High
  • ADAP $1.48
  • AUBN $27.63
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 56.59
  • AUBN 59.12
  • Support Level
  • ADAP $0.23
  • AUBN $23.13
  • Resistance Level
  • ADAP $0.28
  • AUBN $25.00
  • Average True Range (ATR)
  • ADAP 0.02
  • AUBN 0.90
  • MACD
  • ADAP 0.00
  • AUBN -0.01
  • Stochastic Oscillator
  • ADAP 87.96
  • AUBN 43.89

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About AUBN Auburn National Bancorporation Inc.

Auburn National Bancorp Inc operates as a bank holding company, which offers checking, savings, transaction deposit accounts and certificates of deposit, and is an active residential mortgage lender in its primary service area. The Bank's primary service area includes the cities of Auburn and Opelika, Alabama and nearby surrounding areas in East Alabama, predominantly in Lee County. The Bank also offers commercial, financial, agricultural, real estate construction and consumer loan products and other financial services. The Bank also provides automated teller machine (ATM) services in East Alabama and operates ATM machines. The Bank offers Visa Checkcards, which are debit cards. The Bank offers online banking, bill payment and other electronic banking services through its Internet website.

Share on Social Networks: